pseudouridine has been researched along with Disease Exacerbation in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Avila-Pacheco, J; Clish, CB; Coresh, J; Denburg, MR; Feldman, HI; Grams, ME; He, J; Hsu, CY; Kalim, S; Kimmel, PL; Parsa, A; Rao, P; Rebholz, CM; Rhee, EP; Shou, H; Sondheimer, J; Surapaneni, A; Townsend, R; Vasan, RS; Waikar, SS; Wen, D; Xie, D; Yu, B; Zheng, Z; Zhou, L; Zhou, W | 1 |
Chapman, A; Gao, G; Kim, K; Trott, JF; Weiss, RH | 1 |
Calcagno, G; Cataldo, PT; Foggia, M; Intrieri, M; Oriani, G; Pane, F; Piazza, M; Sacchetti, L; Salvatore, F; Zarrilli, F | 1 |
1 trial(s) available for pseudouridine and Disease Exacerbation
Article | Year |
---|---|
Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course.
Topics: Adult; Creatinine; Disease Progression; Female; Humans; Indoles; Kidney; Kidney Function Tests; Longitudinal Studies; Male; Organ Size; Patient Acuity; Polycystic Kidney, Autosomal Dominant; Predictive Value of Tests; Prognosis; Pseudouridine; Renal Insufficiency; Uric Acid | 2019 |
2 other study(ies) available for pseudouridine and Disease Exacerbation
Article | Year |
---|---|
Metabolite profiling of CKD progression in the chronic renal insufficiency cohort study.
Topics: Biomarkers; Cohort Studies; Disease Progression; Histamine; Humans; Prospective Studies; Pseudouridine; Renal Insufficiency, Chronic | 2022 |
Pseudouridine and 1-ribosylpyridin-4-one-3-carboxamide (PCNR) serum concentrations in human immunodeficiency virus type 1-infected patients are independent predictors for AIDS progression.
Topics: Acquired Immunodeficiency Syndrome; Adult; beta 2-Microglobulin; CD4-CD8 Ratio; Disease Progression; Female; HIV-1; Humans; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Pseudouridine; Pyridones; Ribonucleosides; Time Factors | 1996 |